Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001579428-13-000004
Filing Date
2013-10-30
Accepted
2013-10-29 17:49:44
Documents
1
Effectiveness Date
2013-10-30
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 7934
  Complete submission text file 0001579428-13-000004.txt   8983
Mailing Address 45 ROCKEFELLER PLAZA, SUITE 2000 NEW YORK NY 10111
Business Address 45 ROCKEFELLER PLAZA, SUITE 2000 NEW YORK NY 10111 212-203-5072
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-199018 | Film No.: 131177327